The following table reconciles cash and cash equivalents reported in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows:


(In thousands)	June 30, 2026		December 31, 2025
Cash and cash equivalents in the Balance Sheets	$	192,138	$	190,022
Cash and cash equivalents included in Current assets of discontinued operations	10,143		21,115
Restricted cash included in the following line items:
Other current assets	1,652		1,674
Current assets of discontinued operations	748		1,043
Other assets	3,144		2,806
Total cash, cash equivalents and restricted cash in the Statements of Cash Flows	$	207,825	$	216,660

The following table presents the components of accounts receivable, net, as reported in the Consolidated Balance Sheets:


(In thousands)	June 30, 2026		December 31, 2025
Accounts receivable	$	381,330	$	382,582
Less: Allowance for credit losses	(13,338)		(11,205)
Accounts receivable, net	$	367,992	$	371,377

Credit loss expense for continuing operations, included in “Selling, general and administrative expenses” on the Consolidated Statements of Income (Loss), was $0.8 million and $0.9 million for the three months ended June 30, 2026 and 2025, respectively, and $3.4 million and $1.6 million for the six months ended June 30, 2026 and 2025, respectively.

The following table presents the components of accrued expenses as reported in the Consolidated Balance Sheets:


(In thousands)	June 30, 2026		December 31, 2025
Accrued rent	$	53,630	$	60,660
Accrued employee compensation and benefits	32,076		40,942
Accrued taxes	15,099		14,315
Accrued other	61,173		53,776
Total accrued expenses	$	161,978	$	169,693

Other operating expense, net, of $5.0 million and $20.4 million for the three and six months ended June 30, 2026, respectively, primarily consisted of transaction costs, including costs associated with the Merger, of $4.4 million and $20.2 million, respectively. Other operating expense, net, also included net losses (gains) from the sale or disposal of operating assets of $0.3 million and $(0.3) million, respectively, with the remaining expense driven by bank fees.

Other operating income, net, of $0.3 million and $6.1 million for the three and six months ended June 30, 2025, respectively, primarily consisted of net gains from the sale or disposal of operating assets of $0.7 million and $7.2 million, respectively. These gains were partially offset by transaction costs associated with structural initiatives and financial advisory services of $0.1 million and $0.7 million, respectively, and bank fees.